E 717
Pill imprint E 717 has been identified as Meprobamate 400 mg.
Meprobamate is used in the treatment of anxiety and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy.
Meprobamate 400 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Meprobamate Images
- Imprint:
-
E 717
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- United Research Laboratories/Mutual Pharmaceutical Company
More Meprobamate resources
- Meprobamate (Wolters Kluwer)
- meprobamate (Cerner Multum)
- Trancot (Micromedex) - Includes Dosage Information
- meprobamate (Micromedex) - Includes Dosage Information
- Meprobamate (AHFS DI)
- Meprobamate (FDA)
- Meprobamate (Wolters Kluwer)


